Related Experiment Video
Updated: Jul 11, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Dendritic cell immunotherapy for stage IV melanoma
Michael G E O'Rourke1, Maree K Johnson, Catherine M Lanagan
1Queensland Radium Institute, South Brisbane, Qld, Australia. mgeorourke@bigpond.com
Melanoma Research
|September 22, 2007
Summary
Dendritic cell immunotherapy shows promise for advanced melanoma. Cryopreserved dendritic cells achieved complete clinical responses in some patients with stage IV melanoma, supporting further trials.
Area of Science:
- Immunology
- Oncology
- Cancer Therapy
Background:
- Antitumour immune response boosting is crucial for solid malignancies.
- Previous trials reported isolated complete responses, but lacked replication.
- Dendritic cell-based immunotherapy showed promise in prior melanoma studies.
Purpose of the Study:
- To evaluate cryopreserved dendritic cell immunotherapy in a second cohort of stage IV melanoma patients.
- To confirm the potential of dendritic cell-based therapy in advanced melanoma.
- To assess the efficacy of cryopreserved dendritic cells in eliciting clinical responses.
Main Methods:
- A cohort of 46 patients with stage IV melanoma received cryopreserved dendritic cell-based immunotherapy.
- The therapy involved a dendritic cell/irradiated autologous tumour cell vaccine.
- Objective clinical responses were monitored.
Main Results:
- Three out of 46 patients achieved complete remission of all detectable disease.
- An additional three patients experienced partial clinical responses.
- This study is the first to demonstrate complete clinical responses using cryopreserved dendritic cells in advanced cancer.
Conclusions:
- Dendritic cell-based immunotherapy shows potential for a subset of stage IV melanoma patients.
- Cryopreserved dendritic cells can elicit complete clinical responses in advanced cancer.
- Further randomized controlled trials are warranted to validate these findings.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...